Holen Sie sich die Stockscreener-App
12.10
1.39%
-0.17
Handel nachbörslich:
12.10
Schlusskurs vom Vortag:
$12.27
Offen:
$12.35
24-Stunden-Volumen:
103.71K
Relative Volume:
0.45
Marktkapitalisierung:
$134.54M
Einnahmen:
$385.79M
Nettoeinkommen (Verlust:
$-18.67M
KGV:
-7.1156
EPS:
-1.7005
Netto-Cashflow:
$1.25M
1W Leistung:
-3.43%
1M Leistung:
-7.07%
6M Leistung:
+11.21%
1J Leistung:
-2.97%
1-Tages-Spanne:
$12.03
$12.40
1-Wochen-Bereich:
$12.03
$12.81
52-Wochen-Spanne:
$9.22
$15.46
Medifast Inc Stock (MED) Company Profile
Firmenname
Medifast Inc
Sektor
Branche
Telefon
(410) 581-8042
Adresse
1501 S. CLINTON STREET, BALTIMORE, MD
Compare MED vs ROL, SCI, HRB, FTDR, ANDG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MED
Medifast Inc
|
12.10 | 136.43M | 385.79M | -18.67M | 1.25M | -1.7005 |
ROL
Rollins Inc
|
47.10 | 22.39B | 3.84B | 529.30M | 621.14M | 1.0945 |
SCI
Service Corp International
|
69.68 | 9.63B | 4.33B | 535.79M | 486.05M | 3.79 |
HRB
H R Block Inc
|
38.09 | 4.75B | 3.91B | 736.10M | 760.88M | 5.6238 |
FTDR
Frontdoor Inc
|
63.64 | 4.44B | 2.12B | 260.00M | 385.00M | 3.5067 |
ANDG
Andersen Group Inc
|
38.38 | 4.52B | 838.69M | -130.17M | 0 | 5.0103 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Hochstufung | DA Davidson | Underperform → Neutral |
| 2024-06-05 | Herabstufung | DA Davidson | Neutral → Underperform |
| 2023-10-13 | Eingeleitet | Stephens | Equal-Weight |
| 2022-11-04 | Herabstufung | DA Davidson | Buy → Neutral |
| 2022-08-04 | Herabstufung | Jefferies | Buy → Hold |
| 2021-01-25 | Hochstufung | Jefferies | Hold → Buy |
| 2020-11-05 | Hochstufung | DA Davidson | Neutral → Buy |
| 2020-06-25 | Eingeleitet | B. Riley FBR | Buy |
| 2020-02-27 | Herabstufung | Jefferies | Buy → Hold |
| 2019-11-08 | Herabstufung | Dougherty & Company | Buy → Neutral |
| 2019-07-25 | Eingeleitet | Jefferies | Buy |
| 2018-11-08 | Hochstufung | Sidoti | Neutral → Buy |
| 2018-03-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2017-09-15 | Bestätigt | DA Davidson | Buy |
| 2016-08-04 | Bestätigt | Wunderlich | Hold |
| 2016-01-11 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-11-30 | Herabstufung | Sidoti | Buy → Neutral |
| 2015-10-05 | Hochstufung | Sidoti | Neutral → Buy |
| 2014-11-07 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2014-08-08 | Bestätigt | Imperial Capital | Outperform |
| 2014-04-23 | Bestätigt | Imperial Capital | Outperform |
| 2013-09-06 | Eingeleitet | Imperial Capital | Outperform |
| 2012-11-06 | Bestätigt | Northland Securities | Outperform |
| 2012-07-27 | Hochstufung | Northland Securities | Market Perform → Outperform |
| 2012-07-09 | Herabstufung | Standpoint Research | Buy → Hold |
| 2012-01-30 | Eingeleitet | Standpoint Research | Buy |
Alle ansehen
Medifast Inc Aktie (MED) Neueste Nachrichten
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year? - Yahoo Finance
Medifast chief legal officer Jason Groves resigns; company begins search for successor - Investing.com UK
Medifast (MED) Files 8-K Announcing Executive Separation Agreement with Jason Groves - Minichart
Medifast's Jason L. Groves resigns as Chief Legal Officer & Corporate Secretary - TradingView
[8-K] MEDIFAST INC Reports Material Event - Stock Titan
MED News Today | Why did Medifast stock drop today? $MED - MarketBeat
Medifast (MED) director takes equity awards instead of cash for board service - Stock Titan
Medifast (NYSE: MED) director Kiai Parsa takes equity grants in lieu of cash fees - Stock Titan
Medifast (MED) director receives 11,680 RSUs as annual fee compensation - Stock Titan
Medifast (NYSE: MED) director receives 11,680 restricted stock units award - Stock Titan
Medifast (NYSE: MED) director awarded 11,680 restricted stock units in fee grant - Stock Titan
Cash-settled RSU grant boosts Medifast (MED) director derivative holdings - Stock Titan
Medifast Inc (NYSE: MED) director Jeffrey Rose files routine Form 3 - Stock Titan
Medifast (NYSE: MED) director details 657,590 indirect shares - Stock Titan
What is Zacks Research's Forecast for Medifast Q2 Earnings? - MarketBeat
Medifast Appoints Nicholas Johnson as New CEO and Amends 2012 Share Incentive Plan - Minichart
Medifast Names Nicholas Johnson as CEO - Moomoo
MED Technical Analysis | Trend, Signals & Chart Patterns | MEDIFAST INC (NYSE:MED) - ChartMill
Medifast Taps Johnson to Succeed Chard as CEO - Moomoo
Medifast names Nicholas Johnson as CEO effective June 1 By Investing.com - Investing.com South Africa
Nicholas Johnson becomes Medifast (NYSE: MED) CEO as investors back equity plan - Stock Titan
Medifast, Inc. Approves Board Elections - marketscreener.com
Medifast names Nicholas Johnson as CEO effective June 1 - Investing.com
Medifast confirms appointment of Nicholas Johnson as chief executive officer - marketscreener.com
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer - Business Wire
Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026 - MSN
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do - Sahm
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do - GlobeNewswire Inc.
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes - Sahm
MEDIFAST INC (MED) Surges +1.12%, Nearing $13.22 Resistance 2026-05-19Call Spread Alert - thelegaladvocate.com
Citadel reports 6.5% stake in MEDIFAST (MED) in joint Schedule 13G - Stock Titan
MED | Medifast, Inc. FinancialsIncome Statement - Quiver Quantitative
Charles Schwab (MED) reports 631,539 shares, 5.74% stake (03/31/2026) - Stock Titan
Renaissance Holdings amends Schedule 13G: 773,710 shares in MED (MED) - Stock Titan
Why Medifast's $15 Cash Per Share Makes It A Strong Buy (NYSE:MED) - Seeking Alpha
Medifast director Scott Schlackman buys $62,950 in company stock By Investing.com - Investing.com Nigeria
Medifast director Scott Schlackman buys $62,950 in company stock - Investing.com
Medifast (MED) director Scott Schlackman adds 5,000 shares in open-market buys - Stock Titan
TradingKey - TradingKey
Medifast: Worth Putting On A Watchlist (NYSE:MED) - Seeking Alpha
Why is Medifast stock surging despite weak Q1? $30M cost-cut plan - MSN
Document - SEC.gov
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y - The Globe and Mail
Medifast | 8-K: Medifast Announces First Quarter 2026 Financial Results - Moomoo
Medifast, Inc. (NYSE:MED) Q1 2026 Earnings Call Transcript - Insider Monkey
Medifast Q1 2026 Deep Dive: EPS Beats by 63.5%, Revenue Down 34% - AlphaStreet
Medifast, Inc. Q1 2026 Financial Results: Revenue, Net Loss, and Shareholder Equity Analysis - Minichart
Medifast Q1 2026 slides: coach productivity surges amid revenue miss By Investing.com - Investing.com Australia
Medifast Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Medifast Q1 2026 beats EPS forecast, stock dips By Investing.com - Investing.com South Africa
Finanzdaten der Medifast Inc-Aktie (MED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):